Zobrazeno 1 - 10
of 105
pro vyhledávání: '"Judith Haas"'
Publikováno v:
BMC Neurology, Vol 23, Iss 1, Pp 1-10 (2023)
Abstract Introduction/Aims Chronic inflammatory demyelinating polyradiculoneuropathy (CIDP) is characterized by progressive weakness and sensory loss, often affecting patient’s ability to walk and perform activities of daily living independently. F
Externí odkaz:
https://doaj.org/article/15e507b42be345d48f21464a8d935653
Autor:
Firas Fneish, Niklas Frahm, Melanie Peters, David Ellenberger, Judith Haas, Micha Löbermann, Dieter Pöhlau, Anna-Lena Röper, Sarah Schilling, Alexander Stahmann, Herbert Temmes, Friedemann Paul, Uwe K. Zettl
Publikováno v:
Vaccines, Vol 11, Iss 12, p 1859 (2023)
Several studies reported post-SARS-CoV-2-vaccination (PV) symptoms. Even people with multiple sclerosis (PwMS) have concerns about disease activity following the SARS-CoV-2 vaccination. We aimed to determine the proportion of PwMS with PV relapses, t
Externí odkaz:
https://doaj.org/article/fd7179958544494b9322499460d272e4
Autor:
Niklas Frahm, Firas Fneish, David Ellenberger, Judith Haas, Micha Loebermann, Tina Parciak, Melanie Peters, Dieter Pöhlau, Jeff Rodgers, Anna-Lena Röper, Sarah Schilling, Alexander Stahmann, Herbert Temmes, Uwe K. Zettl, Rodden M. Middleton
Publikováno v:
The Lancet Regional Health. Europe, Vol 22, Iss , Pp 100502- (2022)
Summary: Background: Vaccines offer people with multiple sclerosis (PwMS) an effective protection against severe COVID-19 disease courses. However, representative real-world data on the tolerability of SARS-CoV-2 vaccines in PwMS are limited. We aime
Externí odkaz:
https://doaj.org/article/9a6b3486974f4051a56463f363e21125
Autor:
Lisa-Marie Ohle, David Ellenberger, Peter Flachenecker, Tim Friede, Judith Haas, Kerstin Hellwig, Tina Parciak, Clemens Warnke, Friedemann Paul, Uwe K. Zettl, Alexander Stahmann
Publikováno v:
Scientific Reports, Vol 11, Iss 1, Pp 1-9 (2021)
Abstract In 2001, the German Multiple Sclerosis Society, facing lack of data, founded the German MS Registry (GMSR) as a long-term data repository for MS healthcare research. By the establishment of a network of participating neurological centres of
Externí odkaz:
https://doaj.org/article/3654845ac2f64275b780abb489f96ac1
Autor:
Clemens Warnke, Stephanie Stock, Martin Hellmich, Gereon R Fink, Heidrun Golla, Raymond Voltz, Judith Haas, Julia Strupp, Volker Limmroth, Anne Müller, Eckhard Bonmann, Kim Dillen, Thomas Dojan, Solveig Ungeheuer, Petra Schmalz, Angelika Staß, Vanessa Mildenberger, Yasemin Goereci, Veronika Dunkl, Oliver Cornely, Alexander Stahmann, Peter Löcherbach, Lothar Burghaus, Kathrin Gerbershagen, Gereon Nelles, Thomas Joist, Herbert Temmes
Publikováno v:
BMJ Open, Vol 12, Iss 1 (2022)
Externí odkaz:
https://doaj.org/article/aeb5d20b31af45b9a736d4b1e4a29421
Autor:
Niklas Frahm, Melanie Peters, Jörg Bätzing, David Ellenberger, Manas K. Akmatov, Judith Haas, Paulus S. Rommer, Alexander Stahmann, Uwe K. Zettl, Jakob Holstiege
Publikováno v:
Therapeutic Advances in Neurological Disorders, Vol 14 (2021)
Background: The manifestation of multiple sclerosis (MS) in childhood and adolescence occurs in 3%−5% of all MS cases. However, the immunomodulatory and symptomatic treatment options in this population group are still limited. Objective: We aimed t
Externí odkaz:
https://doaj.org/article/5aa4ca49ffe54e85a974a9dbbd0a8893
Autor:
Tjalf Ziemssen, Holger Albrecht, Judith Haas, Luisa Klotz, Michael Lang, Christoph Lassek, Stephan Schmidt, Benjamin Ettle, Ulf Schulze-Topphoff
Publikováno v:
Frontiers in Neurology, Vol 12 (2021)
Background: Fingolimod (Gilenya®) is approved for adult and pediatric patients with highly active relapsing–remitting multiple sclerosis (RRMS).Objectives: The objective was to describe the effectiveness of fingolimod in young adults compared to o
Externí odkaz:
https://doaj.org/article/b252bcf66d554500b9f3b23e910b99a2
Autor:
Paulus Stefan Rommer, David Ellenberger, Kerstin Hellwig, Judith Haas, Dieter Pöhlau, Alexander Stahmann, Uwe Klaus Zettl
Publikováno v:
Therapeutic Advances in Neurological Disorders, Vol 13 (2020)
Background: Multiple sclerosis (MS) is an inflammatory and neurodegenerative disease whose aetiology is not fully understood. The female sex is clearly predominant, with a sex ratio between 2 and 3. In primary progressive MS the sex ratio almost bala
Externí odkaz:
https://doaj.org/article/5f6a73843bba4018bce56492ce33e7b6
Autor:
Christoph Ohlmeier, Holger Gothe, Judith Haas, Ulrike Osowski, Carina Weinhold, Sarah Blauwitz, Niklas Schmedt, Wolfgang Galetzka, Fabian Berkemeier, Björn Tackenberg, Martin Stangel
Publikováno v:
PLoS ONE, Vol 15, Iss 5, p e0231846 (2020)
BACKGROUND:Multiple Sclerosis (MS) is a chronic inflammatory, immune mediated disease of the central nervous system, with Relapsing Remitting MS (RRMS) being the most common type. Within the last years, the status of high disease activity (HDA) has b
Externí odkaz:
https://doaj.org/article/3a6bdb4973334d388433c8f90cbd7b0d
Autor:
Niklas Frahm, Firas Fneish, David Ellenberger, Judith Haas, Micha Löbermann, Melanie Peters, Dieter Pöhlau, Anna-Lena Röper, Sarah Schilling, Alexander Stahmann, Herbert Temmes, Friedemann Paul, Uwe Klaus Zettl
Publikováno v:
Journal of Clinical Medicine; Volume 12; Issue 11; Pages: 3640
Despite protection from severe COVID-19 courses through vaccinations, some people with multiple sclerosis (PwMS) are vaccination-hesitant due to fear of post-vaccination side effects/increased disease activity. The aim was to reveal the frequency and
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6eebb4083d787ea234eb94f33f647383
https://doi.org/10.3390/jcm12113640
https://doi.org/10.3390/jcm12113640